Clopidogrel and genetic testing: is it necessary for everyone?

Abstract excerpt

Clopidogrel is a widely used antiplatelet agent to treat and prevent a variety of atherothrombotic diseases. More than a decade after its initial Food and Drug Administration approval, studies have emerged raising concerns regarding its possible reduced efficacy in patients who have impaired conversion of clopidogrel to its active metabolite (ie, poor metabolizers). Research has implicated genetic variations in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Arteriosclerosis
• Share to Clinical Trials as Topic
• Share to Clopidogrel